1.	Cesium-131 Seed Brachytherapy Plus Subtotal Resection for Lung Cancer Patients Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0908010555, NCT01757158
2.	Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000588879, CALGB-30610, RTOG 0538, NCT00632853
3.	Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC) Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: SCLC, NCT01487499
4.	Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 100138, 10-C-0138, NCT01143545
5.	177Lutetium-DOTA-Octreotate Therapy in Somatostatin Receptor-Expressing Neuroendocrine Neoplasms Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 78,256, NCT01237457
6.	Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000690182, RTOG-1012, NCT01262560
7.	Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J12127, NA_00078659, NCT01797159
8.	Her2 and TGFBeta CTLs in Treatment of Her2 Positive Malignancy Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 24486-HERCREEM, HERCREEM, NCT00889954
9.	Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Pro00017361, NCT00921739
10.	Tumor Cell Vaccines With ISCOMATRIX(Trademark) Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 110041, 11-C-0041, NCT01258868
11.	Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: I 191511, NCI-2011-03568, NCT01522820
12.	Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000462091, WSU-C-2975, WSU-0509002942, NCT00303901
13.	A Natural History Study of Patients Receiving High-Dose Rate Brachytherapy Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 to 90 Sponsor: NCI Protocol IDs: 090100, 09-C-0100, NCT00924027
14.	Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 08-095, NCT01349647
15.	Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CMT - 01-10, NCT01396551
16.	Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: NBI-LC-001, NCT01679470
17.	DIBH Proton Planning Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCC 13910, NCT01386697